While completing her PhD in epidemiology and health systems management at the University of Basel, Anna also studied medicine and conducted research at Harvard and the University of Zurich medical schools. In 2019, before taking up her roles as a medical director at Klinik Hirslanden and as chief of strategy for preventive medicine and longevity for the Hirslanden Group, she completed the International Directors Program at INSEAD.
In addition to being an entrepreneur and currently holding selected board positions in healthtech, AI, and longevity medicine, she is a board member of the Finnish-Swiss Chamber of Commerce, a health advisor to Forbes, a mentor at ETH, and a faculty member at the University of St. Gallen Executive School. She also gives talks on sustainable and planetary health, preventive medicine and longevity for the UN and the World Economic Forum, among others.